Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation

Journal of Reproductive Immunology

Volumn 89, Issue 1, 2011, Pages 70-77

  Weinberg, Adriana ^a   Enomoto, Laura ^a,b   Marcus, Roland ^a   Canniff, Jennifer ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cell mediated immunity; Estrogen; Human immunodeficiency virus; Progesterone; Regulatory t cells; Varicella zoster virus

Indexed keywords

ESTROGEN; INTERLEUKIN 10; PROGESTERONE; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HERPES ZOSTER; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; LUTEAL PHASE; LYMPHOCYTE PROLIFERATION; MENSTRUAL CYCLE; PRIORITY JOURNAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, VIRAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HERPESVIRUS 3, HUMAN; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-10; MENSTRUAL CYCLE; MIDDLE AGED; PROGESTERONE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 79955020005     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.11.009     Document Type: Article

References (44)

1. Abel K., Rourke T., Lu D., Bost K., McChesney M.B., Miller C.J. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J. Infect. Dis. 2004, 190:1697-1705.
2. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 2004, 5:266-271.
3. Arruvito L., Sanz M., Banham A.H., Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 2007, 178:2572-2578.
4. Ashcroft G.S., Mills S.J., Lei K., Gibbons L., Jeong M.J., Taniguchi M., Burow M., Horan M.A., Wahl S.M., Nakayama T. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J. Clin. Invest. 2003, 111:1309-1318.
5. Bengtsson A.K., Ryan E.J., Giordano D., Magaletti D.M., Clark E.A. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 2004, 104:1404-1410.
6. Bento C.A., Hygino J., Andrade R.M., Saramago C.S., Silva R.G., Silva A.A., Linhares U.C., Brindeiro R., Tanuri A., Rosenzwajg M., Klatzmann D., Andrade A.F. IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment. AIDS 2009, 23:9-18.
7. Cenci S., Toraldo G., Weitzmann M.N., Roggia C., Gao Y., Qian W.P., Sierra O., Pacifici R. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:10405-10410.
8. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 1998, 339:285-291.
9. Correale J., Arias M., Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 1998, 161:3365-3374.
10. Dosiou C., Lathi R.B., Tulac S., Huang S.T., Giudice L.C. Interferon-related and other immune genes are downregulated in peripheral blood leukocytes in the luteal phase of the menstrual cycle. J. Clin. Endocrinol. Metab. 2004, 89:2501-2504.
11. Dosiou C., Hamilton A.E., Pang Y., Overgaard M.T., Tulac S., Dong J., Thomas P., Giudice L.C. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J. Endocrinol. 2008, 196:67-77.
12. Ehring G.R., Kerschbaum H.H., Eder C., Neben A.L., Fanger C.M., Khoury R.M., Negulescu P.A., Cahalan M.D. A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes. J. Exp. Med. 1998, 188:1593-1602.
13. Elenkov I.J., Wilder R.L., Bakalov V.K., Link A.A., Dimitrov M.A., Fisher S., Crane M., Kanik K.S., Chrousos G.P. IL-12 TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab. 2001, 86:4933-4938.
14. Enomoto L.M., Kloberdanz K.J., Mack D.G., Elizabeth D., Weinberg A. Ex vivo effect of estrogen and progesterone compared with dexamethasone on cell-mediated immunity of HIV-infected and uninfected subjects. J. Acquir. Immune Defic. Syndr. 2007, 45:137-143.
15. Gao Y., Qian W.P., Dark K., Toraldo G., Lin A.S., Guldberg R.E., Flavell R.A., Weitzmann M.N., Pacifici R. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16618-16623.
16. Gillgrass A.E., Ashkar A.A., Rosenthal K.L., Kaushic C. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 2003, 77:9845-9851.
17. Gillgrass A.E., Tang V.A., Towarnicki K.M., Rosenthal K.L., Kaushic C. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue. J. Virol. 2005, 79:3117-3126.
18. Kalo-Klein A., Witkin S.S. Candida albicans: cellular immune system interactions during different stages of the menstrual cycle. Am. J. Obstet. Gynecol. 1989, 161:1132-1136.
19. Lambert K.C., Curran E.M., Judy B.M., Milligan G.N., Lubahn D.B., Estes D.M. Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. J. Immunol. 2005, 175:5716-5723.
20. Latham K.A., Zamora A., Drought H., Subramanian S., Matejuk A., Offner H., Rosloniec E.F. Estradiol treatment redirects the isotype of the autoantibody response and prevents the development of autoimmune arthritis. J. Immunol. 2003, 171:5820-5827.
21. Lavreys L., Baeten J.M., Martin H.L., Overbaugh J., Mandaliya K., Ndinya-Achola J., Kreiss J.K. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS 2004, 18:695-697.
22. Lim A., Tan D., Price P., Kamarulzaman A., Tan H.Y., James I., French M.A. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007, 21:1525-1534.
23. Liu H.B., Loo K.K., Palaszynski K., Ashouri J., Lubahn D.B., Voskuhl R.R. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J. Immunol. 2003, 171:6936-6940.
24. Marzi M., Vigano A., Trabattoni D., Villa M.L., Salvaggio A., Clerici E., Clerici M. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 1996, 106:127-133.
25. Mcclain M.A., Gatson N.N., Powell N.D., Papenfuss T.L., Gienapp I.E., Song F., Shawler T.M., Kithcart A., Whitacre C.C. Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J. Immunol. 2007, 179:8146-8152.
26. Miyaura H., Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J. Immunol. 2002, 168:1087-1094.
27. Mo R., Chen J., Grolleau-Julius A., Murphy H.S., Richardson B.C., Yung R.L. Estrogen regulates CCR gene expression and function in T lymphocytes. J. Immunol. 2005, 174:6023-6029.
28. Mor G., Sapi E., Abrahams V.M., Rutherford T., Song J., Hao X.Y., Muzaffar S., Kohen F. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J. Immunol. 2003, 170:114-122.
29. Piccinni M.P., Giudizi M.G., Biagiotti R., Beloni L., Giannarini L., Sampognaro S., Parronchi P., Manetti R., Annunziato F., Livi C., et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 1995, 155:128-133.
30. Polanczyk M.J., Carson B.D., Subramanian S., Afentoulis M., Vandenbark A.A., Ziegler S.F., Offner H. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J. Immunol. 2004, 173:2227-2230.
31. Polanczyk M.J., Hopke C., Vandenbark A.A., Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res. 2006, 84:370-378.
32. Salama A.D., Chitnis T., Imitola J., Ansari M.J., Akiba H., Tushima F., Azuma M., Yagita H., Sayegh M.H., Khoury S.J. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2003, 198:71-78.
33. Sandner S.E., Clarkson M.R., Salama A.D., Sanchez-Fueyo A., Domenig C., Habicht A., Najafian N., Yagita H., Azuma M., Turka L.A., Sayegh M.H. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J. Immunol. 2005, 174:3408-3415.
34. Siston A.M., Rasmussen S.A., Honein M.A., Fry A.M., Seib K., Callaghan W.M., Louie J., Doyle T.J., Crockett M., Lynfield R., Moore Z., Wiedeman C., Anand M., Tabony L., Nielsen C.F., Waller K., Page S., Thompson J.M., Avery C., Springs C.B., Jones T., Williams J.L., Newsome K., Finelli L., Jamieson D.J. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010, 303:1517-1525.
35. Soldan S.S., Alvarez Retuerto A.I., Sicotte N.L., Voskuhl R.R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 2003, 171:6267-6274.
36. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004, 112:38-43.
37. Stramer S.L., Glynn S.A., Kleinman S.H., Strong D.M., Caglioti S., Wright D.J., Dodd R.Y., Busch M.P. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N. Engl. J. Med. 2004, 351:760-768.
38. Stringer E.M., Kaseba C., Levy J., Sinkala M., Goldenberg R.L., Chi B.H., Matongo I., Vermund S.H., Mwanahamuntu M., Stringer J.S. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am. J. Obstet. Gynecol. 2007, 197. 144 e1-144 e8.
39. Stringer E.M., Levy J., Sinkala M., Chi B.H., Matongo I., Chintu N., Stringer J.S. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS 2009, 23:1377-1382.
40. Wang C.C., Mcclelland R.S., Overbaugh J., Reilly M., Panteleeff D.D., Mandaliya K., Chohan B., Lavreys L., Ndinya-Achola J., Kreiss J.K. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 2004, 18:205-209.
41. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol. Today 1993, 14:353-356.
42. Weinberg A., Betensky R.A., Zhang L., Ray G. Effect of shipment, storage, anticoagulant, and cell separation on lymphocyte proliferation assays for human immunodeficiency virus-infected patients. Clin. Diagn. Lab. Immunol. 1998, 5:804-807.
43. Zang Y.C., Halder J.B., Hong J., Rivera V.M., Zhang J.Z. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J. Neuroimmunol. 2002, 124:106-114.
44. Zenclussen A.C., Gerlof K., Zenclussen M.L., Sollwedel A., Bertoja A.Z., Ritter T., Kotsch K., Leber J., Volk H.D. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol. 2005, 166:811-822.